PER Podcast Sessions

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Joyce O’Shaughnessy, MD; Hope S. Rugo, MD; and Matthew P. Goetz, MD, discuss innovations in targeting TROP2 in triple-negative breast cancer treatment. Learning Objectives Upon successful completion of this activity, you should be better prepa...

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Hope S. Rugo, MD; and Joyce O’Shaughnessy, MD, discuss pivotal trials of antibody-drug conjugates in HR+/HER2- and triple-negative subtypes of metastatic breast cancer. Learning Objectives Upon successful completion of this activity, you shoul...

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Benjamin P. Levy, MD; Ticiana Leal, MD; Aaron Lisberg, MD; and Christine M. Lovly, MD, PhD, FASCO, discuss current and emerging treatment strategies targeting HER2 and TROP2 in patients with advanced or metastatic non–small cell lung cancer (NS...

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Vinay Puduvalli, MD; Manmeet Ahluwalia, MD, MBA; Stephen Bagley, MD, MSCE; and Angela Waanders, MD, MPH, MS; discuss advancements in targeted therapies to treat adult and pediatric low- and high-grade gliomas. Learning Objectives Upon successf...

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Drs Stacey Cohen, Aparna Parikh, Kanwal Raghav, and John Strickler discuss advancements in targeted therapies to treat adult metastatic colorectal cancer. Learning Objectives Upon successful completion of this activity, you should be better pr...

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Alex A. Adjei, MD, PhD, FACP; Sandip Patel, MD, FASCO; and Jeremy Segal, MD, PhD, discuss the emerging data and clinical strategies for targeting c-MET overexpression and MET genomic alterations in non–small cell lung cancer (NSCLC), including ...

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Gail J. Roboz, MD; Hagop Kantarjian, MD; Catherine Lai, MD, MPH; and Amer Zeidan, MBBS, MHS; discuss current best practices and emerging strategies in acute myeloid leukemia (AML) management. Learning Objectives Upon successful completion of...

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Eileen O’Reilly, MD, and Brian Wolpin, MD, MPH, discuss current principles for molecular testing and emerging targeted therapy approaches for patients with metastatic pancreatic ductal adenocarcinoma. Learning Objectives Upon successful comp...

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Mohamad Mohty, MD, PhD and Surbhi Sidana, MD discuss recent advances in treating and managing newly diagnosed multiple myeloma (NDMM). Learning Objectives Upon successful completion of this activity, you should be better prepared to: Analyz...

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Mohamad Mohty, MD, PhD and Surbhi Sidana, MD discuss recent advances in treatment options for relapsed/refractory multiple myeloma (R/R MM). Learning Objectives Upon successful completion of this activity, you should be better prepared to: ...

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Jonathan W. Goldman, MD; Percy Lee, MD, FASTRO; Erminia Massarelli, MD, PhD, MS; and Misty D. Shields, MD, PhD; discuss recent advances and emerging approaches—including immunotherapy, DLL3-targeted agents, and antibody-drug conjugates—for pati...

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Balazs Halmos, MD, MS; Enriqueta Felip, MD, PhD; and Julia Rotow, MD; discuss the latest evidence in managing EGFR-mutated non–small cell lung cancer (NSCLC), with a focus on personalized treatment strategies based on factors such as molecular ...

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Gabriela Hobbs, MD; John O. Mascarenhas, MD; and Naveen Pemmaraju, MD; discuss recent advances in therapies for myelofibrosis (MF), polycythemia vera (PV), and essential thrombocytopenia (ET). Learning Objectives Upon successful completion of ...

Thank you for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Rachel N. Grisham, MD; Oladapo O. Yeku, MD, PhD, FACP; and Ramez N. Eskander, MD, explore new frontiers in the treatment of ovarian cancer, including advances in biomarker-driven decision-making, maintenance strategies, and emerging targeted...

Episode Description In this podcast, ALS expert Terry Heiman-Patterson, MD, discusses best practices for ALS diagnosis and use of targeted therapy. Learning Objectives Upon successful completion of this activity, you should be better prepared to: Apply recommended diagnostic criteria and strategies to make an early, accurate diagnosis of ALS Discuss the mechanisms of action, efficacy, and s...

Episode Description In this podcast, ALS expert clinician-researcher Richard Bedlack MD, PhD, discusses targeted therapy for ALS and the role of individualized, multidisciplinary care to optimize patient outcomes. Learning Objectives Upon successful completion of this activity, you should be better prepared to: Discuss the mechanisms of action, efficacy, and safety of approved and emerging ...

Episode Description In this episode of the PER® podcast, we explore the evolving landscape of HER2-mutant non–small cell lung cancer (NSCLC)—a rare and historically difficult-to-treat subset of lung cancer. Join Millie Das, MD, from Stanford/VA Palo Alto; and Eric Kumar Singhi, MD, from The University of Texas MD Anderson Cancer Center; as they delve into emerging clinical data on next-generati...

Episode Description In this podcast, experts Andy Guinigundo, MSN, RN, CNP, ANP-BC, FAPO, and Fred Hirsch, MD, PhD, review the evolving treatment landscape for limited-stage small-cell lung cancer (LS-SCLC) and extensive-stage (ES) SCLC, including a discussion of the latest strategies for managing common and severe treatment-related adverse events. Acknowledgment of Educational Grant Support T...

Episode Description This PER® Show Me Your Care Plan!™ featured podcast brings together two medical oncologists and an oncology nurse to discuss the latest advances in the management of platinum-resistant ovarian cancer (PROC). The expert panel reviews current and emerging therapies, with a special focus on the management of adverse events associated with mirvetuximab soravtansine (MIRV) and ot...

Tardive dyskinesia (TD), a neurological disorder characterized by involuntary movement, is commonly associated with exposure to antipsychotic medication. The disorder can have significant impacts on patient quality of life due to functional challenges and social stigmatization. Comprehensive assessment of TD burden and severity is needed to guide treatment decisions and optimize outcomes. In th...

This PER®Spectives™ podcast examines opportunities for extended treatment intervals associated with newer therapies for patients with neovascular age-related macular degeneration or diabetic macular edema. In this podcast, experts Arshad Khanani, MD, Ferhina Ali, MD, and Michael Singer, MD, offer real-world data and personal insights into the use of these agents — and corticosteroid implants fo...

This podcast explores the diagnosis and management of postpartum depression with a focus on the importance of screening all postpartum women and treatment options. Two faculty, Sarah Nagle-Yang, MD, and Lindsey Lebin, MD, discuss the importance of an early diagnosis with each other, and a patient shares her journey living with postpartum depression. Faculty Lindsay Lebin, MD Assistant Profes...

This podcast explores the management of thalassemia with a focus on the disease burden, current therapy, and emerging gene therapy.  Two faculty, Hanny Al-Samkari, MD, and Kevin H.M. Kuo, MD, MSc, FRCPC, discuss with each other and with a patient sharing their journey living with thalassemia. Faculty Hanny Al-Samkari, MD Classical Hematologist and Clinical Investigator Division of Hematology ...

This podcast features engaging commentary from experts in the clinical management of generalized myasthenia gravis— James Howard, Jr, MD and Nicholas Sylvestri, MD. These experts discuss the burden of disease associated with the disorder, its pathogenesis in terms of the complement system, and the clinical considerations for incorporating appropriate targeted therapy to improve health-related o...

This PER®Spectives™ podcast examines treatment of presbyopia with a focus on new and emerging topical therapies. In this podcast, experts Mile Brujic, OD, FAAO, and  Jay Pepose, MD, PhD, describe these agents and how to select patients with presbyopia who will benefit from topical treatment. Faculty: Mile Brujic, OD, FAAO Premier Vision Group Bowling Green, OH Jay Pepose M.D., Ph.D. Pepose Vi...

Optometrists play a critical role in first-line screening and monitoring of patients with neovascular age-related macular degeneration (or nAMD) and diabetic macular edema (or DME). Where patients require more advanced care, optometrists refer them to retina specialists. Join Drs Ferhina Ali, Carl Regillo, Jessica Steen and Mohammad Rafieetary as they review the role of optometrists in managing...

This PER® Spectives™ featured podcast examines the important role of co-management of glaucoma between optometrists and ophthalmologists .Expert faculty review the selection of traditional and novel topical therapies, and also patient selection for micro-incisional glaucoma surgery (MIGS). Faculty Danica J. Marrelli, OD, FAAO, AAO College of Optometry, University of Houston Houston, TX Ale...

This podcast provides a review of some of the key highlights from the Controversies in Modern Eye Care meeting held in April 2023. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did. Faculty David S. Boyer, MD Retina-Vitreous Associates Medical Group Los Angeles, CA Tina Mac Donald, OD, CDCES, FAAO WesternU Health Los Angel...

Welcome to a podcast based on learning about the lid: optimizing recognition, diagnosis, and treatment of Demodex Blepharitis and Blepharoptosis.  In this podcast, we will hear from Dr Mile Brujic and Dr Cecelia Koetting. Faculty Mile Brujic, OD, FAAO Partner Premier Vision Group Bowling Green, OH Cecelia Koetting, OD, FAAO, DipABO Optometrist Denver, CO

In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients. Faculty Steven Leibowitz, MD Associate Clinical Professor, Oculoplastics and Orbit Jules Stein Eye Institute UCLA School of Medicine Los Angeles, CA R...

In this podcast, two experts discuss the diagnosis and treatment of Parkinson disease psychosis. In their conversation, they discuss examples of patients they have encountered. They also discuss the results of recent clinical trials of new therapies and the importance of a multispecialty approach for these patients. Faculty Gus Alva, MD, DFAPA Medical Director, Senior Brain Health Hoag Hospit...

Neurotrophic keratitis (NK) is a rare condition caused by trigeminal nerve damage, which results in decreased or absent corneal sensitivity and breakdown of the corneal epithelium. If not recognized and managed appropriately, it can lead to corneal ulceration and loss of vision. However, early diagnosis and treatment can improve outcomes. This featured podcast includes an interview with an opt...

Thanks for your interest in this podcast. Please read this important program information before listening. Access to the posttest and instructions for claiming credit for participating are included below. This PER® Spectives™ podcast examines the recent increase in the demand for dermal fillers and neuromodulators, and the corresponding increase in the number of products available for health ca...

Thanks for your interest in this podcast. Please read this important program information before listening. Access to the post-test and to claim credit for participating is included below. This PER® Spectives™ podcast includes a discussion with 3 experts on health disparities that negatively impact patients with cystic fibrosis (CF). Access to care, insurance costs, and unintended bias are just...

Meibomian gland dysfunction (MGD) is a complex, multifactorial disorder that can lead to altered tear film composition and ocular surface disease. In fact, MGD is one of the most common causes of dry eye disease (DED). Although multiple treatment options are available, therapies that target the underlying pathophysiology of the disease are lacking. Emerging agents with novel mechanisms for trea...

This podcast features engaging commentary from experts in the clinical management of patients with sickle cell disease:  Nirmish Shad, MD from Duke University Medical Center, Matthew Heeney, MD Matthew Heeney, MD from Harvard Medical School, and Charles R. Jonassaint, PhD, MHS from University of Pittsburgh School of Medicine. These experts review clinical guidelines, interpret clinical data reg...

Our ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable alterations. Many therapies are currently available o...